Literature DB >> 20601625

Dietary cholesterol reverses resistance to diet-induced weight gain in mice lacking Niemann-Pick C1-Like 1.

Lin Jia1, Yinyan Ma, George Liu, Liqing Yu.   

Abstract

Niemann-Pick C1-Like 1 (NPC1L1) mediates intestinal cholesterol absorption. NPC1L1 knockout (L1-KO) mice were recently shown to be resistant to high-fat diet (HFD)-induced obesity in one study, which was contrary to several other studies. Careful comparison of dietary compositions in these studies implies a potential role of dietary cholesterol in regulating weight gain. To examine this potential, wild-type (WT) and L1-KO mice were fed one of three sets of diets for various durations: (1) a HFD without added cholesterol for 5 weeks; (2) a high-carbohydrate diet with or without added cholesterol for 5 weeks; or (3) a synthetic HFD with or without added cholesterol for 18 weeks. We found that L1-KO mice were protected against diet-induced weight gain only on a diet without added cholesterol but not on a diet containing 0.16% or 0.2% (w/w) cholesterol, an amount similar to a typical Western diet, regardless of the major energy source of the diet. Food intake and intestinal fat absorption were similar between the two genotypes. Intestinal cholesterol absorption was blocked, and fecal cholesterol excretion increased in L1-KO mice. Under all diets, L1-KO mice were protected from hepatosteatosis. In conclusion, increasing dietary cholesterol restores diet-induced weight gain in mice deficient in NPC1L1-dependent cholesterol absorption.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20601625      PMCID: PMC2936752          DOI: 10.1194/jlr.M008599

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  54 in total

1.  Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters.

Authors:  K E Berge; H Tian; G A Graf; L Yu; N V Grishin; J Schultz; P Kwiterovich; B Shan; R Barnes; H H Hobbs
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

2.  Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta.

Authors:  J J Repa; G Liang; J Ou; Y Bashmakov; J M Lobaccaro; I Shimomura; B Shan; M S Brown; J L Goldstein; D J Mangelsdorf
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

Review 3.  Gastrointestinal regulatory peptides and their effects on fat tissue.

Authors:  Ishita D Majumdar; Horst C Weber
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-02       Impact factor: 3.243

4.  The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys.

Authors:  M van Heek; D S Compton; H R Davis
Journal:  Eur J Pharmacol       Date:  2001-03-09       Impact factor: 4.432

5.  Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters.

Authors:  M van Heek; T M Austin; C Farley; J A Cook; G G Tetzloff; H R Davis
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

6.  Evidence for a Niemann-pick C (NPC) gene family: identification and characterization of NPC1L1.

Authors:  J P Davies; B Levy; Y A Ioannou
Journal:  Genomics       Date:  2000-04-15       Impact factor: 5.736

7.  Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemia.

Authors:  Shusuke Yagi; Masashi Akaike; Ken-ichi Aihara; Takashi Iwase; Kazue Ishikawa; Sumiko Yoshida; Yuka Sumitomo-Ueda; Kenya Kusunose; Toshiyuki Niki; Koji Yamaguchi; Kunihiko Koshiba; Yoichiro Hirata; Munkhbaatar Dagvasumberel; Yoshio Taketani; Noriko Tomita; Hirotsugu Yamada; Takeshi Soeki; Tetsuzo Wakatsuki; Toshio Matsumoto; Masataka Sata
Journal:  J Atheroscler Thromb       Date:  2010-02-12       Impact factor: 4.928

8.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

Review 9.  The core gut microbiome, energy balance and obesity.

Authors:  Peter J Turnbaugh; Jeffrey I Gordon
Journal:  J Physiol       Date:  2009-06-02       Impact factor: 5.182

10.  Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry.

Authors:  M S Bosner; L G Lange; W F Stenson; R E Ostlund
Journal:  J Lipid Res       Date:  1999-02       Impact factor: 5.922

View more
  14 in total

1.  Acceleration of biliary cholesterol secretion restores glycemic control and alleviates hypertriglyceridemia in obese db/db mice.

Authors:  Kai Su; Nadezhda S Sabeva; Yuhuan Wang; Xiaoxi Liu; Joshua D Lester; Jingjing Liu; Shuang Liang; Gregory A Graf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-11-07       Impact factor: 8.311

2.  Muscle-specific deletion of comparative gene identification-58 (CGI-58) causes muscle steatosis but improves insulin sensitivity in male mice.

Authors:  Ping Xie; Anil K G Kadegowda; Yinyan Ma; Feng Guo; Xianlin Han; Miao Wang; Leanne Groban; Bingzhong Xue; Hang Shi; Huihua Li; Liqing Yu
Journal:  Endocrinology       Date:  2015-03-09       Impact factor: 4.736

3.  TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis.

Authors:  Li Ye; Sandra Kleiner; Jun Wu; Rajan Sah; Rana K Gupta; Alexander S Banks; Paul Cohen; Melin J Khandekar; Pontus Boström; Rina J Mepani; Dina Laznik; Theodore M Kamenecka; Xinyi Song; Wolfgang Liedtke; Vamsi K Mootha; Pere Puigserver; Patrick R Griffin; David E Clapham; Bruce M Spiegelman
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

4.  Ezetimibe restores biliary cholesterol excretion in mice expressing Niemann-Pick C1-Like 1 only in liver.

Authors:  Weiqing Tang; Lin Jia; Yinyan Ma; Ping Xie; Jamie Haywood; Paul A Dawson; Jian Li; Liqing Yu
Journal:  Biochim Biophys Acta       Date:  2011-06-12

5.  Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels.

Authors:  Ping Xie; Hongling Zhu; Lin Jia; Yinyan Ma; Weiqing Tang; Youlin Wang; Bingzhong Xue; Hang Shi; Liqing Yu
Journal:  Atherosclerosis       Date:  2014-10-17       Impact factor: 5.162

Review 6.  Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.

Authors:  Lin Jia; Jenna L Betters; Liqing Yu
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

7.  Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis.

Authors:  Lin Jia; Yinyan Ma; Shunxing Rong; Jenna L Betters; Ping Xie; Soonkyu Chung; Nanping Wang; Weiqing Tang; Liqing Yu
Journal:  J Lipid Res       Date:  2010-08-10       Impact factor: 5.922

8.  Macrophage CGI-58 deficiency activates ROS-inflammasome pathway to promote insulin resistance in mice.

Authors:  Hongming Miao; Juanjuan Ou; Yinyan Ma; Feng Guo; Zhenggang Yang; Melvin Wiggins; Chaohong Liu; Wenxia Song; Xianlin Han; Miao Wang; Qiang Cao; Bik-Ho Florence Chung; Dan Yang; Houjie Liang; Bingzhong Xue; Hang Shi; Lixia Gan; Liqing Yu
Journal:  Cell Rep       Date:  2014-04-03       Impact factor: 9.423

9.  Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease.

Authors:  Ornella de Bari; Brent A Neuschwander-Tetri; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  J Lipids       Date:  2011-11-03

10.  Microbiota prevents cholesterol loss from the body by regulating host gene expression in mice.

Authors:  Chun-Yan Zhong; Wei-Wei Sun; Yinyan Ma; Hongling Zhu; Pan Yang; Hong Wei; Ben-Hua Zeng; Qian Zhang; Yu Liu; Wen-Xia Li; Yixin Chen; Liqing Yu; Zhi-Yuan Song
Journal:  Sci Rep       Date:  2015-05-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.